Table 1. Mutations found in THF bypass products and in the control plasmids.
Substrate | Nucleotide inserted opposite the THF | Additional mutations downstream of the THF position | |||
---|---|---|---|---|---|
Type of mutation a | Distance from the lesion site (nt) | Position in the URA3 gene b | Position in the vector c | ||
THF | C | A → G | - 444 | 4516 | |
A | C → T | - 378 | 4450 | ||
A | G → C | - 368 | 4440 | ||
A | C ins | - 367 | 4439 | ||
A | TC → AA | - 24 | 629 | 4096 | |
C | T → A | + 34 | 571 | 4038 | |
T | A → C | + 46 | 559 | 4030 | |
A | A → C | + 92 | 513 | 3984 | |
A | GAT del | + 108 | 497 | 3968 | |
A | A → C | + 168 | 437 | 3908 | |
C | C → T | + 193 | 412 | 3883 | |
A | G → T | + 213 | 392 | 3863 | |
A | G del | + 338 | 267 | 3738 | |
T | G del | + 341 | 264 | 3735 | |
T | A del | + 498 | 107 | 3578 | |
C | G → C | + 626 | 3450 | ||
A | A del | + 799 | 3277 | ||
T | A del | + 799 | 3277 | ||
C | C → T | + 980 | 3096 | ||
C | G → C | + 1064 | 3021 | ||
A | A → T | + 1397 | 2688 | ||
T | C → T | + 1405 | 2680 | ||
A | C → T | + 1529 | 2556 | ||
Control | NA | A del | - 498 | 4575 | |
NA | C → T | - 460 | 4537 | ||
NA | C ins | - 368 | 4445 | ||
NA | T del | - 325 | 4402 | ||
NA | C → G | - 221 | 826 | 4298 | |
NA | C → T | - 34 | 639 | 4111 | |
NA | A → G | + 236 | 369 | 3840 | |
NA | G del | + 376 | 229 | 3700 | |
NA | A del | + 498 | 107 | 3578 | |
NA | T → C | + 610 | 3466 | ||
NA | T del | + 784 | 3292 | ||
NA | C → T | + 907 | 3178 | ||
NA | C → T | + 1012 | 3073 | ||
NA | G → T | + 1209 | 2876 | ||
NA | C → T | + 1242 | 2843 | ||
NA | A → C | + 1447 | 2638 | ||
NA | C → T | + 1621 | 2812 |
aNucleotide changes in the strand complementary to the THF-containing strand are shown.
bNumbering for the URA3 gene is from the first nucleotide of the open reading frame.
cNumbering for the vector if from the first nucleotide following the ARS4 sequence.
nt, nucleotide; del, deletion; ins, insertion; NA, not applicable.